tradingkey.logo

Oncology Institute Inc

TOI

3.240USD

+0.250+8.36%
終値 09/18, 16:00ET15分遅れの株価
302.23M時価総額
損失額直近12ヶ月PER

Oncology Institute Inc

3.240

+0.250+8.36%
詳細情報 Oncology Institute Inc 企業名
The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at 83 clinic locations across 15 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, radiation, programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. It also provides management services to 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
企業情報
企業コードTOI
会社名Oncology Institute Inc
上場日Mar 13, 2020
最高経営責任者「CEO」Dr. Daniel Virnich, M.D.
従業員数825
証券種類Ordinary Share
決算期末Mar 13
本社所在地18000 Studebaker Rd
都市CERRITOS
証券取引所NASDAQ Capital Market Consolidated
United States of America
郵便番号90703
電話番号15627353226
ウェブサイトhttps://theoncologyinstitute.com/
企業コードTOI
上場日Mar 13, 2020
最高経営責任者「CEO」Dr. Daniel Virnich, M.D.
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.18M
-1.69%
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
712.03K
+51.10%
Mr. Robert Ross Carter
Mr. Robert Ross Carter
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
235.17K
-0.68%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
198.04K
--
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
193.04K
-0.92%
Ms. Anne Mcgeorge
Ms. Anne Mcgeorge
Independent Chairman of the Board
Independent Chairman of the Board
183.35K
--
Mr. Gabriel Ling
Mr. Gabriel Ling
Independent Director
Independent Director
109.06K
--
Ms. Kristin England
Ms. Kristin England
Chief Administrative Officer
Chief Administrative Officer
98.04K
--
Mr. Mark L. Pacala
Mr. Mark L. Pacala
Independent Director
Independent Director
--
--
Ms. Karen M. Johnson
Ms. Karen M. Johnson
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.18M
-1.69%
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
712.03K
+51.10%
Mr. Robert Ross Carter
Mr. Robert Ross Carter
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
235.17K
-0.68%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
198.04K
--
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
193.04K
-0.92%
Ms. Anne Mcgeorge
Ms. Anne Mcgeorge
Independent Chairman of the Board
Independent Chairman of the Board
183.35K
--
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
事業別USD
会社名
収益
比率
Dispensary revenue
49.29M
47.21%
FFS revenue
35.57M
34.07%
Capitated revenue
17.50M
16.76%
Clinical research trials and other revenue
2.04M
1.96%
データなし
事業別
地域別
事業別USD
会社名
収益
比率
Dispensary revenue
49.29M
47.21%
FFS revenue
35.57M
34.07%
Capitated revenue
17.50M
16.76%
Clinical research trials and other revenue
2.04M
1.96%
株主
更新時刻: Tue, Aug 19
更新時刻: Tue, Aug 19
株主統計
種類
株主統計
株主統計
比率
M33 Growth LLC
9.12%
The Vanguard Group, Inc.
4.58%
OncologyCare Partners LLC
4.40%
TIFF Advisory Services, Inc.
3.89%
Deerfield Management Company, L.P.
3.59%
他の
74.43%
株主統計
株主統計
比率
M33 Growth LLC
9.12%
The Vanguard Group, Inc.
4.58%
OncologyCare Partners LLC
4.40%
TIFF Advisory Services, Inc.
3.89%
Deerfield Management Company, L.P.
3.59%
他の
74.43%
種類
株主統計
比率
Investment Advisor
14.04%
Hedge Fund
9.69%
Venture Capital
9.17%
Investment Advisor/Hedge Fund
6.93%
Individual Investor
4.49%
Corporation
4.40%
Research Firm
0.40%
Private Equity
0.27%
Bank and Trust
0.16%
他の
50.47%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
119
39.72M
44.51%
-19.63M
2025Q1
137
46.36M
52.04%
-13.47M
2024Q4
138
45.05M
59.62%
-19.81M
2024Q3
139
50.89M
67.39%
-11.59M
2024Q2
143
57.80M
76.77%
-3.05M
2024Q1
146
56.10M
75.87%
-3.90M
2023Q4
143
57.48M
77.79%
-4.30M
2023Q3
176
58.70M
79.97%
-14.73M
2023Q2
180
58.28M
81.90%
-25.39M
2023Q1
176
66.92M
93.93%
-18.56M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
M33 Growth LLC
13.75M
15.41%
-673.68K
-4.67%
Jun 05, 2025
The Vanguard Group, Inc.
1.75M
1.96%
-3.67K
-0.21%
Mar 31, 2025
OncologyCare Partners LLC
4.11M
4.61%
--
--
Mar 26, 2025
TIFF Advisory Services, Inc.
2.98M
3.34%
--
--
Mar 31, 2025
Deerfield Management Company, L.P.
3.36M
3.77%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
252.19K
0.28%
+7.02K
+2.86%
Mar 31, 2025
Balyasny Asset Management LP
2.15M
2.41%
+421.77K
+24.44%
Mar 31, 2025
Geode Capital Management, L.L.C.
385.75K
0.43%
+38.40K
+11.06%
Mar 31, 2025
Virnich (Daniel)
1.18M
1.33%
-20.39K
-1.69%
May 21, 2025
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
KeyAI